How big is BrightSpring Health Services, Inc.?

As of Jun 18, BrightSpring Health Services, Inc. has a market capitalization of $3.75 billion, with recent net sales of $11.57 billion and a net profit of $35.08 million.

Market Cap: As of Jun 18, BrightSpring Health Services, Inc. has a market capitalization of 3,753.42 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, BrightSpring Health Services, Inc. reported net sales of 11,567.96 million and a net profit of 35.08 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 1,647.86 million and total assets of 6,198.23 million.

What does BrightSpring Health Services, Inc. do?

BrightSpring Health Services, Inc. is a small-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $2.878 billion and a net profit of $9 million. Key metrics include a market cap of $3.75 billion, a P/E ratio of 37.00, and a debt-to-equity ratio of 1.50.

Overview: <BR>BrightSpring Health Services, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 2,878 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 9 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 3,753.42 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 37.00 <BR>Debt Equity: 1.50 <BR>Return on Equity: 6.69% <BR>Price to Book: 2.22<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Should I buy, sell or hold BrightSpring Health Services, Inc.?

Is BrightSpring Health Services, Inc. technically bullish or bearish?

As of September 3, 2025, BrightSpring Health Services, Inc. shows a bullish technical trend with strong momentum indicators, despite a mildly bearish weekly KST, and has significantly outperformed the S&P 500 over the past year.

As of 3 September 2025, the technical trend for BrightSpring Health Services, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. The daily moving averages also support a bullish stance. However, the weekly KST is mildly bearish, which suggests some caution. The Dow Theory indicates a bullish trend on the monthly timeframe, while the OBV is bullish on the monthly as well.<BR><BR>In terms of performance, BrightSpring has outperformed the S&P 500 significantly over the past year, with a return of 83.25% compared to the S&P's 17.14%. Overall, the current technical stance is bullish with strong momentum indicators, despite some mixed signals in the KST.

Is BrightSpring Health Services, Inc. overvalued or undervalued?

As of October 17, 2025, BrightSpring Health Services, Inc. is considered undervalued with a P/E ratio of 37, an EV to EBITDA of 12.65, and a PEG ratio of 0.12, outperforming the S&P 500 with a year-to-date return of 74.57%.

As of 17 October 2025, the valuation grade for BrightSpring Health Services, Inc. moved from expensive to attractive, indicating a shift towards being undervalued. The company appears to be undervalued based on several key ratios, including a P/E ratio of 37, an EV to EBITDA of 12.65, and a PEG ratio of 0.12, which suggests strong growth potential relative to its price. <BR><BR>In comparison to its peers, BrightSpring's P/E ratio of 37.784 is slightly higher than the industry average, while its EV to EBITDA of 13.2063 is more favorable, indicating better valuation metrics. Notably, the company has outperformed the S&P 500 with a year-to-date return of 74.57% compared to the index's 13.30%, reinforcing the attractiveness of its current valuation.